Showing results (81-90 of 108) with videos related to

Sort By:
Pageof 11
JAMA|June 3, 1988
Treatment of steroid-resistant acute graft-vs-host disease by in vivo administration of an anti-T-cell ricin A chain immunotoxinN A Kernan, V Byers, P J Scannon, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 1989
Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cellsC Bordignon, S F Yu, C A Smith, et al.
The Journal of Experimental Medicine|November 1, 1995
Human CD8 transgene regulation of HLA recognition by murine T cellsD M LaFace, M Vestberg, Y Yang, et al.
Blood|March 1, 1984
Allogeneic bone marrow transplantation for patients with acute nonlymphocytic leukemiaR Dinsmore, D Kirkpatrick, N Flomenberg, et al.
Bone Marrow Transplantation|February 26, 2013
Haploidentical hematopoietic SCT increases graft-versus-tumor effect against renal cell carcinomaT Budak-Alpdogan, C T Sauter, C P Bailey, et al.
Blood|June 1, 1990
Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemiaM Hauch, M V Gazzola, T Small, et al.
Bone Marrow Transplantation|April 30, 2013
Interleukin-15 administration increases graft-versus-tumor activity in recipients of haploidentical hematopoietic SCTC T Sauter, C P Bailey, M M Panis, et al.
International Journal of Radiation Oncology, Biology, Physics|July 1, 1994
Hyperfractionated total lymphoid irradiation and cyclophosphamide for preparation of previously transfused patients undergoing HLA-identical marrow transplantation for severe aplastic anemiaH Castro-Malaspina, B Childs, J Laver, et al.
Transplantation|July 1, 1990
Evidence that appearance of thymulin in plasma follows lymphoid chimerism and precedes development of immunity in patients with lethal combined immunodeficiency transplanted with T cell-depleted haploidentical marrowG S Incefy, N Flomenberg, G Heller, et al.
Blood|July 9, 1999
T-cell depletion plus salvage immunotherapy with donor leukocyte infusions as a strategy to treat chronic-phase chronic myelogenous leukemia patients undergoing HLA-identical sibling marrow transplantationW R Drobyski, M J Hessner, J P Klein, et al.
Pageof 11